This study examined the transforming activities of nitrosated and nonnitrosated coal dust extracts in BALB/3T3 clone A31-1-13 cells. At a concentration of 2.08 milligrams/milliliter (mg/ml) coal dust, the cloning efficiency of the BALB/3T3 cells was about 50%. A dose dependent reduction in cloning efficiency by both nitrosated and nonnitrosated extracts was noted at concentrations ranging from 0.26 to 8.3mg/ml. In the transformation experiments morphological transformation was induced both by nitrosated and nonnitrosated coal dust extracts. The number of transformed foci in the coal dust extract treated cultures was higher than background levels. A dose related response was noted which was about 1.5 to 2.3 fold higher with nitrosated than with nonnitrosated coal dust extract. The growth rate of the coal dust extract transformed cells was higher than that of normal BALB/3T3 cells. The maximum growth density of transformed cells was 2.7 times than that of the nontransformed cells. When cells from transformed foci were plated in soft agar medium, colonies developed. There was no effect of initial seeding density on CFE in soft agar medium. The average CFE of the transformed cells in soft agar medium ranged from 8.7% to 11.2%, which was significantly higher than the 0.23 to 0.6% of nontransformed cells. The authors concluded that coal dust extracts with or without nitrosation are capable of inducing morphological transformation in BALB/3T3 cells in a dose response manner. These findings support a hypothesis of coal mine dust causation of gastric cancer in coal miners.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.